Thyrotropin (TSH)-secreting pituitary tumors may be found in two oppos
ite clinical situations: the hyperthyroidism secondary to thyrotroph a
denomas, also called central hyperthyroidism, and the long-standing pr
imary hypothyroidism which can be accompanied by a compensatory pituit
ary enlargement. TSH-secreting pituitary adenomas belong to the syndro
mes of ''inappropriate secretion of TSH'' (IST). The adjective ''inapp
ropriate'' indicates the lack of the expected suppression of TSH secre
tion when free thyroid hormone levels are actually elevated, as in the
other forms of thyrotoxicosis. Moreover, TSH-omas have to be differen
tiated from the non-neoplastic form of IST which is due to resistance
to thyroid hormone. Differently, pituitary hyperplasia, which is rever
sible on thyroid hormone replacement, is the more frequent cause of a
pituitary mass occurring in the context of untreated primary hypothyro
idism. Failure or delay in the recognition of the above clinical situa
tions may cause dramatic consequences, such as unnecessary pituitary s
urgery in hypothyroid patients or improper thyroid ablation in those w
ith central hyperthyroidism. In contrast, early diagnosis and proper t
reatment of TSH-secreting pituitary tumors prevents the appearance of
signs and symptoms of mechanical compression of the adjacent structure
s by the expanding tumor mass (visual field defects, headache and hypo
pituitarism).